Medtronic to pay $51 million to resolve U.S. medical device probes

  • In US
  • 2018-12-04 23:55:40Z
  • By By Nate Raymond

By Nate Raymond

BOSTON (Reuters) - Medtronic Plc said on Tuesday it would pay $50.9 million to resolve U.S. Justice Department probes into how companies it later acquired marketed medical devices, including one meant to treat a vascular defect in the brain.

As part of the accord, ev3 Inc, which Medtronic now owns, will pay $17.9 million and plead guilty to a charge related to its marketing of a neurovascular medical device for unproven and potentially dangerous uses, federal prosecutors in Boston said.

The misdemeanor charge relates to the Onyx Liquid Embolic System, which the U.S. Food and Drug Administration in 2005 approved for the limited use of blocking blood flow to arteriovenous malformations in the brain.

Prosecutors said that ev3's sales staff from 2005 to 2009 marketed Onyx for other unapproved uses outside of the brain and continued to do so even after FDA officials warned ev3 executives in 2008 about safety concerns they had.

"ev3 disregarded laws designed to protect patient safety," U.S. Attorney Andrew Lelling in Boston said in a statement.

Medtronic in a statement said it was also resolving two other Justice Department investigations involving conduct that largely concluded before it acquired Covidien Plc in 2015. Covidien itself bought Minnesota-based ev3 in 2010.

In one case, the Justice Department alleged Covidien paid kickbacks to hospitals to induce them to use its Solitaire mechanical thrombectomy device, which is intended to restore blood flow in certain stroke patients.

The scheme resulted in false claims for payment being submitted to the government healthcare programs Medicare and Medicaid, the department said.

The $13 million settlement in that case stemmed from a lawsuit filed in a federal court in California in 2015 by a former Covidien employee, Jeffrey Faatz, under the False Claims Act.

That law allows whistleblowers to sue companies on the government's behalf to recover fraudulently paid-out taxpayer money. For his role in the case, Faatz will receive a nearly $2.02 million reward, the Justice Department said.

Medtronic said it had also agreed to pay $20 million to resolve an investigation related to various market-development and physician-engagement activities involving Covidien and ev3.

Medtronic said it did not admit wrongdoing as part of the $13 million and $20 million settlements. In the Boston case, ev3 will plead guilty to introducing adulterated medical devices into interstate commerce.

"Medtronic is committed to maintaining the highest standards of ethical conduct and compliance with all applicable regulatory guidelines," Medtronic said.

The case is U.S. v. ev3 Inc, U.S. District Court, District of Massachusetts, No. 18-cr-10461.

(Reporting by Nate Raymond in Boston; Editing by Marguerita Choy and Peter Cooney)


More Related News

Trump's Justice Department Uses Julian Assange as Stalking Horse to Make Journalism a Crime

Photo Illustration by The Daily Beast/GettyThe Justice Department's sweeping new "superseding" indictment on Thursday of WikiLeaks founder Julian Assange under the Espionage Act is a bombshell that poses grave dangers for freedom of the press. The indictment would criminalize the encouragement of leaks of newsworthy classified information, criminalize the acceptance of such information, and criminalize publication of it. That's criminalizing journalism.And it doesn't matter whether you think Assange is a journalist, or whether WikiLeaks is a news organization. The theory that animates the indictment targets the very essence of journalistic activity: the gathering and dissemination of...

Trump Authorizes Barr to Declassify Documents in
Trump Authorizes Barr to Declassify Documents in 'Spying' Probe

The president, in a memorandum, directed U.S. intelligence agencies to cooperate with Barr's review, which he has said would look into allegations by Trump and his allies that his campaign was spied upon and that various figures in the Justice Department and the FBI were trying to undermine him. "Today's action will help ensure that all Americans learn the truth about the events that occurred, and the actions that were taken, during the last presidential election and will restore confidence in our public institutions," the White House said in a press release on Thursday night.

In new charges against Assange, groups see cause for concern
In new charges against Assange, groups see cause for concern

WASHINGTON (AP) - New charges filed against WikiLeaks founder Julian Assange quickly drew alarm Thursday from media organizations and others. The groups are concerned that the Justice Department is charging Assange for actions that ordinary journalists do routinely in their jobs.

Trump Justice Department Crosses New Line, Charges Assange With Publishing U.S. Secrets
Trump Justice Department Crosses New Line, Charges Assange With Publishing U.S. Secrets

Daniel Leal-Olivas/GettyIn a stunning escalation of the Trump administration's war on the press, the Justice Department has indicted WikiLeaks founder Julian Assange for revealing government secrets under the Espionage Act. It's the first time a publisher has been charged under the World War I-era law.The indictment charges Assange with 16 counts of receiving or disclosing material leaked by then-Army intelligence analyst Chelsea Manning in 2009 and 2010. The charges invoke broad provisions of the Espionage Act that make it a crime to disclose or retain any defense information knowing it "could be used to injure" the U.S. The act has no exception for reporters or publishers, but prior...

US charges WikiLeaks founder with publishing classified info
US charges WikiLeaks founder with publishing classified info

WASHINGTON (AP) - The U.S. filed new charges Thursday against Wikileaks founder Julian Assange, accusing him of placing the United States at risk of serious harm by publishing thousands of secret and classified documents, including the names of confidential sources for American armed forces.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: US

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.